<code id='5055D5ACD5'></code><style id='5055D5ACD5'></style>
    • <acronym id='5055D5ACD5'></acronym>
      <center id='5055D5ACD5'><center id='5055D5ACD5'><tfoot id='5055D5ACD5'></tfoot></center><abbr id='5055D5ACD5'><dir id='5055D5ACD5'><tfoot id='5055D5ACD5'></tfoot><noframes id='5055D5ACD5'>

    • <optgroup id='5055D5ACD5'><strike id='5055D5ACD5'><sup id='5055D5ACD5'></sup></strike><code id='5055D5ACD5'></code></optgroup>
        1. <b id='5055D5ACD5'><label id='5055D5ACD5'><select id='5055D5ACD5'><dt id='5055D5ACD5'><span id='5055D5ACD5'></span></dt></select></label></b><u id='5055D5ACD5'></u>
          <i id='5055D5ACD5'><strike id='5055D5ACD5'><tt id='5055D5ACD5'><pre id='5055D5ACD5'></pre></tt></strike></i>

          leisure time

          leisure time

          author:hotspot    Page View:28962
          A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT
          Christine Kao/STAT

          Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

          The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

          advertisement

          Here are three CRISPR developments we’re watching in 2024:

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more
          Dispute over threat of extinction posed by artificial intelligence looms over surging industry
          Dispute over threat of extinction posed by artificial intelligence looms over surging industry

          5:08Advancedhumanoidrobot'Sophia'ispicturedatAIforGoodGlobalSummit,inGeneva,Switzerland,July6,2023.P

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          EMA weighs against approval for Mirati's lung cancer drug

          AdobeAEuropeanregulatorypanelhasrecommendedagainstapprovalofalungcancerdrugmadebyMiratiTherapeutics,